DE2023989C3 - Verfahren zur Herstellung von aus Antigen-Trägerstoffgemischen bestehenden und gegebenenfalls Antikörper enthaltenden fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lagerbeständigen Testsubstanzen - Google Patents
Verfahren zur Herstellung von aus Antigen-Trägerstoffgemischen bestehenden und gegebenenfalls Antikörper enthaltenden fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lagerbeständigen TestsubstanzenInfo
- Publication number
- DE2023989C3 DE2023989C3 DE2023989A DE2023989A DE2023989C3 DE 2023989 C3 DE2023989 C3 DE 2023989C3 DE 2023989 A DE2023989 A DE 2023989A DE 2023989 A DE2023989 A DE 2023989A DE 2023989 C3 DE2023989 C3 DE 2023989C3
- Authority
- DE
- Germany
- Prior art keywords
- antigen
- finished
- production
- consist
- test substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000012360 testing method Methods 0.000 title claims description 18
- 238000000034 method Methods 0.000 title claims description 16
- 239000000126 substance Substances 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000000203 mixture Substances 0.000 title claims description 4
- 239000000427 antigen Substances 0.000 claims description 21
- 102000036639 antigens Human genes 0.000 claims description 20
- 108091007433 antigens Proteins 0.000 claims description 20
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 17
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 210000003743 erythrocyte Anatomy 0.000 claims description 9
- 239000004816 latex Substances 0.000 claims description 8
- 229920000126 latex Polymers 0.000 claims description 8
- 241001494479 Pecora Species 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000004793 Polystyrene Substances 0.000 claims description 5
- 229920002223 polystyrene Polymers 0.000 claims description 5
- 239000003899 bactericide agent Substances 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 16
- 239000000725 suspension Substances 0.000 description 16
- 210000002966 serum Anatomy 0.000 description 13
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000000405 serological effect Effects 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 230000004520 agglutination Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 239000011241 protective layer Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229960002155 chlorothiazide Drugs 0.000 description 3
- 229940039227 diagnostic agent Drugs 0.000 description 3
- 239000000032 diagnostic agent Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 108010074605 gamma-Globulins Proteins 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 201000006747 infectious mononucleosis Diseases 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 3
- 210000001685 thyroid gland Anatomy 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 208000024799 Thyroid disease Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IWYGVDBZCSCJGT-UHFFFAOYSA-N 1-(2,5-dimethoxy-4-methylphenyl)-n-methylpropan-2-amine Chemical compound CNC(C)CC1=CC(OC)=C(C)C=C1OC IWYGVDBZCSCJGT-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 229960004906 thiomersal Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUVA1309A HU162690B (enExample) | 1969-05-24 | 1969-05-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2023989A1 DE2023989A1 (de) | 1970-11-26 |
| DE2023989B2 DE2023989B2 (de) | 1973-09-20 |
| DE2023989C3 true DE2023989C3 (de) | 1974-04-18 |
Family
ID=11002274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2023989A Expired DE2023989C3 (de) | 1969-05-24 | 1970-05-15 | Verfahren zur Herstellung von aus Antigen-Trägerstoffgemischen bestehenden und gegebenenfalls Antikörper enthaltenden fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lagerbeständigen Testsubstanzen |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS4948732B1 (enExample) |
| AT (1) | AT306921B (enExample) |
| AU (1) | AU1543770A (enExample) |
| BE (1) | BE750849A (enExample) |
| BG (1) | BG20078A3 (enExample) |
| BR (1) | BR7019244D0 (enExample) |
| CH (1) | CH536627A (enExample) |
| DE (1) | DE2023989C3 (enExample) |
| DK (1) | DK124988B (enExample) |
| FR (1) | FR2053902A5 (enExample) |
| GB (1) | GB1316876A (enExample) |
| HU (1) | HU162690B (enExample) |
| IE (1) | IE34175B1 (enExample) |
| IL (1) | IL34544A (enExample) |
| LU (1) | LU60961A1 (enExample) |
| NL (1) | NL7007469A (enExample) |
| NO (1) | NO129481B (enExample) |
| PL (1) | PL72768B1 (enExample) |
| RO (1) | RO62161A (enExample) |
| SE (1) | SE376090B (enExample) |
| ZA (1) | ZA703369B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA702304B (en) * | 1969-04-22 | 1971-01-27 | Org Nv | Diagnostic test slide |
| US4136162A (en) | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| JPS5338235U (enExample) * | 1976-09-08 | 1978-04-04 | ||
| JPS5340649U (enExample) * | 1976-09-13 | 1978-04-08 | ||
| DE2709625C3 (de) * | 1977-03-05 | 1982-03-04 | Battelle-Institut E.V., 6000 Frankfurt | Verfahren zur wissenschaftlichen, analytischen oder diagnostischen Untersuchung |
| IT1114861B (it) * | 1977-05-12 | 1986-01-27 | Sclavo Inst Sieroterapeut | Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo |
| US4234316A (en) | 1979-04-02 | 1980-11-18 | Fmc Corporation | Device for delivering measured quantities of reagents into assay medium |
| US4387164A (en) | 1980-11-05 | 1983-06-07 | Fmc Corporation | Method and apparatus for chemical analysis using reactive reagents dispersed in soluble film |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU767266A (en) * | 1966-06-29 | 1968-01-04 | Beecham Group Limited | Means for testing the supersensitivity ofthe skin |
| ZA702304B (en) * | 1969-04-22 | 1971-01-27 | Org Nv | Diagnostic test slide |
-
1969
- 1969-05-24 HU HUVA1309A patent/HU162690B/hu unknown
-
1970
- 1970-05-15 DE DE2023989A patent/DE2023989C3/de not_active Expired
- 1970-05-18 ZA ZA703369A patent/ZA703369B/xx unknown
- 1970-05-18 IL IL34544A patent/IL34544A/en unknown
- 1970-05-19 GB GB2409870A patent/GB1316876A/en not_active Expired
- 1970-05-20 IE IE661/70A patent/IE34175B1/xx unknown
- 1970-05-20 CH CH746670A patent/CH536627A/de not_active IP Right Cessation
- 1970-05-20 AT AT450170A patent/AT306921B/de not_active IP Right Cessation
- 1970-05-21 FR FR7018599A patent/FR2053902A5/fr not_active Expired
- 1970-05-22 AU AU15437/70A patent/AU1543770A/en not_active Expired
- 1970-05-22 BR BR219244/70A patent/BR7019244D0/pt unknown
- 1970-05-22 BE BE750849D patent/BE750849A/xx unknown
- 1970-05-22 SE SE7007090A patent/SE376090B/xx unknown
- 1970-05-22 LU LU60961D patent/LU60961A1/xx unknown
- 1970-05-22 NO NO01954/70A patent/NO129481B/no unknown
- 1970-05-22 DK DK264670AA patent/DK124988B/da unknown
- 1970-05-22 NL NL7007469A patent/NL7007469A/xx unknown
- 1970-05-23 PL PL1970140830A patent/PL72768B1/pl unknown
- 1970-05-23 BG BG014769A patent/BG20078A3/xx unknown
- 1970-05-25 RO RO63441A patent/RO62161A/ro unknown
- 1970-05-25 JP JP45044104A patent/JPS4948732B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE34175B1 (en) | 1975-02-19 |
| IL34544A (en) | 1973-05-31 |
| DE2023989A1 (de) | 1970-11-26 |
| DK124988B (da) | 1972-12-18 |
| ZA703369B (en) | 1971-01-27 |
| DE2023989B2 (de) | 1973-09-20 |
| AT306921B (de) | 1973-04-25 |
| NO129481B (enExample) | 1974-04-16 |
| IL34544A0 (en) | 1970-07-19 |
| NL7007469A (enExample) | 1970-11-26 |
| SE376090B (enExample) | 1975-05-05 |
| GB1316876A (en) | 1973-05-16 |
| RO62161A (enExample) | 1977-05-15 |
| HU162690B (enExample) | 1973-03-28 |
| LU60961A1 (enExample) | 1970-07-23 |
| IE34175L (en) | 1970-11-24 |
| CH536627A (de) | 1973-05-15 |
| BG20078A3 (bg) | 1975-10-30 |
| BE750849A (enExample) | 1970-11-03 |
| JPS4948732B1 (enExample) | 1974-12-23 |
| FR2053902A5 (enExample) | 1971-04-16 |
| PL72768B1 (enExample) | 1974-08-30 |
| BR7019244D0 (pt) | 1973-02-08 |
| AU1543770A (en) | 1971-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3852117T2 (de) | Immunoassay mit Verwendung von nichtmetallischen, kolloidalen Teilchen. | |
| DE69306804T2 (de) | Immunologischer test auf festphase | |
| DE3872500T2 (de) | Verwendung eines mit biotin verknuepften immobilisierten rezeptors in einer testvorrichtung, einem testsatz und einer methode zur bestimmung eines liganden. | |
| EP0407904B1 (de) | Verfahren zur Bestimmung eines Analyten | |
| DE2651139C3 (de) | Reagens zur Durchführung eines Direktagglutinationstests zum Schwangerschaftsnachweis und Verfahren zu seiner Herstellung | |
| DE1648999C3 (de) | Verfahren zur immunochemischen Bestimmung von Antigenen und Antikörpern | |
| DE2925565A1 (de) | Inkubations-doppelplatzimmunonachweisverfahren und mittel zur durchfuehrung des verfahrens | |
| DD202178A5 (de) | Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen | |
| DE3002973C2 (enExample) | ||
| DE2608667A1 (de) | Diagnostisches feststoffreagens und verfahren zu dessen herstellung | |
| DE69812312T2 (de) | Standardlösung zur bestimmung der thyroidfunktion | |
| EP0001223A2 (de) | Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz. | |
| DE3626468A1 (de) | Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten | |
| DE2023989C3 (de) | Verfahren zur Herstellung von aus Antigen-Trägerstoffgemischen bestehenden und gegebenenfalls Antikörper enthaltenden fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lagerbeständigen Testsubstanzen | |
| DE3783209T2 (de) | Verfahren und apparat zur bestimmung von immunologischen reaktiven substanzen von klinischem interesse. | |
| DE69831229T2 (de) | Schnelle bestimmung des verhältnisses von biologischen molekülen | |
| DE3105555C2 (enExample) | ||
| DE2463435C2 (de) | Vorrichtung zur Durchführung eines Verfahrens zum Nachweisen von Proteinen und Antikörpern | |
| DE69929059T2 (de) | Verfahren zum bestimmen von physiologisch aktiven komponenten | |
| DE68918286T2 (de) | Verfahren zum testen einer immunologisch aktiven substanz und dafür geeignetes reagenz. | |
| DE1598928A1 (de) | Verfahren zum Nachweis der infektioesen Mononukleose und Nachweisreagenz | |
| DE69610679T2 (de) | Antigen für Enzymimmuntest und Verfahren zur Messung von erythrozytären Antikörpern | |
| DE4429409C1 (de) | Verfahren zur immunologischen Bestimmung von Proteinen und Kit zur Durchführung des Verfahrens | |
| DE2618449A1 (de) | Serumdiagnostische zusammensetzung | |
| DE2638250A1 (de) | Verbessertes verfahren zum nachweisen von antikoerpern und antigenen, sowie vorrichtung zur durchfuehrung des verfahrens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 | ||
| EHJ | Ceased/non-payment of the annual fee |